Evaluation of the treatment and prognosis of the patients with orofacial pain of unknown cause
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The aim of this study was to evaluate the symptoms, diagnoses, clinical treatment and prognoses of patients with orofacial pain of unknown origin. The study included 61 patients (13 males, 48 females, mean age 60.8 years) who experienced orofacial pain of unknown etiology, except for those with definite causes including dental pain, infection, osteomyelitis, and temporomandibular joint disease. Clinical examinations included patients’ clinical signs, radiological examinations (radiographs, CT, MRI, bone scan), blood tests, thermography, electric pulp tests, electrophysiological examinations, and anesthesia for diagnostic purposes. The treatment methods included medication, physiotherapy, dental treatment, periodontal treatment, surgical operation, and consultation, taking into consideration the precise diagnosis and symptoms for each patient. We retrospectively reviewed the medical records and evaluated the treatment duration and prognosis for each diagnosis. There were more female patients than male patients (78.7% female) and the mean age for all participants was 60.8 years. The mean duration of treatment for orofacial pain was 32 months; the traumatic neuropathy group had the shortest duration, 29.1 months, and the trigeminal neuralgia group had the longest duration, 52.9 months. Atypical odontalgia was the most favorable prognosis, followed by psychological pain, trigeminal neuralgia, traumatic neuropathy, and atypical facial pain. In all cases of oral facial pain, a significant relief of symptoms was observed after treatment. The outcome of current medications and physical therapies for patients with unexplained orofacial pain is generally good.
Abstract
The aim of this study was to evaluate the symptoms, diagnoses, clinical treatment and prognoses of patients with orofacial pain of unknown origin. The study included 61 patients (13 males, 48 females, mean age 60.8 years) who experienced orofacial pain of unknown etiology, except for those with definite causes including dental pain, infection, osteomyelitis, and temporomandibular joint disease. Clinical examinations included patients’ clinical signs, radiological examinations (radiographs, CT, MRI, bone scan), blood tests, thermography, electric pulp tests, electrophysiological examinations, and anesthesia for diagnostic purposes. The treatment methods included medication, physiotherapy, dental treatment, periodontal treatment, surgical operation, and consultation, taking into consideration the precise diagnosis and symptoms for each patient. We retrospectively reviewed the medical records and evaluated the treatment duration and prognosis for each diagnosis. There were more female patients than male patients (78.7% female) and the mean age for all participants was 60.8 years. The mean duration of treatment for orofacial pain was 32 months; the traumatic neuropathy group had the shortest duration, 29.1 months, and the trigeminal neuralgia group had the longest duration, 52.9 months. Atypical odontalgia was the most favorable prognosis, followed by psychological pain, trigeminal neuralgia, traumatic neuropathy, and atypical facial pain. In all cases of oral facial pain, a significant relief of symptoms was observed after treatment. The outcome of current medications and physical therapies for patients with unexplained orofacial pain is generally good.
참고문헌 (20)
- Kreisberg MK, "The scope of TMD", orofacial pain (head and neck pain management) in contemporary dental practice, 1997, pp.11, 78~83
- Okeson JP, "Bell's orofacial pain" (1995), Quintessence
- Okeson JP, "Bell's orofacial pains. The Clinical Management of Orofacial Pain" (2005), Quintessence Publishing Co, Inc
- Okeson JP, "The classification of orofacial pains", Oral Maxillofac Surg Clin North Am, 20, pp.133~144 (2008)[DOI]
- Marbach JJ, "Depression, anhedonia and anxiety in temporomandibular joint and other facial pain syndromes", Pain, 11, pp.73~84 (1981)[DOI]
- Gordon A, "Illness behavior and personality in intractable facial pain syndromes", Pain, 17, pp.267~276 (1983)[DOI]
- Mongini F, "Personality characteristics before and after treatment of different head pain syndromes", Cephalgia, 14, pp.368~373 (1994)[DOI]
- Massager N, "Gamma knife surgery for idiopathic trigeminal neuralgia performed using a far-anterior cisternal target and a high dose of radiation", J Neurosurg, 100, pp.597~605 (2004)[DOI]
- Holland M, "The cost-effectiveness of surgery for trigeminal neuralgia in surgically naiv epatients: a retrospective study", Clin Neurol Neurosurg, 137, pp.34~37 (2015)[DOI]
- de Leeuw R, "Orofacial pain: guidelines for assessment, diagnosis, and management. Am J Orthod Dentofacial Orthop 4th ed", pp.158~176 (2008), Quintessence Publishing Co, Inc
- Danzig WN, "Physical therapy as an adjunct to temporomandibular joint therapy", J Prosthet Dent, 49, pp.96~99 (1983)[DOI]
- Vahid Rakhshan, "Common risk factors for postoperative pain following the extraction of wisdom teeth", 대한구강악안면외과학회지, 41(2), pp.59~65 (2015), 대한구강악안면외과학회
- Matthew J. Zdilla, "Screening for variations in anterior digastric musculature prior to correction of post-traumatic anterior open bite by injection of botulinum toxin type A: a technical note", 대한구강악안면외과학회지, 41(3), pp.165~167 (2015), 대한구강악안면외과학회
- Gangarosa L, "Pharmacologic management of TMJ-MPDS", Ear Nose Throat J, 61, pp.670~678 (1982)
- Gregg JM, "A Textbook of Occlusion", pp.351~375 (1983), Quintessence
- Song PC, "The emerging role of botulinum toxin in the treatment of temporomandibular disorders", Oral Dis, 13, pp.253~260 (2007)[DOI]
- Kitt CA, "Trigeminal neuralgia: opportunities for research and treatment", Pain, 85, pp.3~7 (2000)[DOI]
- Zakrzewska JM, "Medical management of trigeminal neuropathic pains", Expert Opin Pharmacother, 11, pp.1239~1254 (2010)[DOI]
- Fromm GH, "Baclofen in the treatment of trigeminal neuralgia: Double-blind study and long-term follow-up", Ann Neuro, 15, pp.240~244 (1984)[DOI]
- Zakrzewska JM, "Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial", Pain, 73, pp.223~230 (1997)[DOI]